awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24626194-02C11DCC-1D38-4126-9586-315B71ACBA2D
Q24626194-02C11DCC-1D38-4126-9586-315B71ACBA2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24626194-02C11DCC-1D38-4126-9586-315B71ACBA2D
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
P2860
Q24626194-02C11DCC-1D38-4126-9586-315B71ACBA2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24626194-02C11DCC-1D38-4126-9586-315B71ACBA2D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61559763622b36628dfec51b71f31e6d11a364e0
P2860
EGFR signaling in breast cancer: bad to the bone.